Synexa Life Sciences celebrates its 20th anniversary Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights.March 3, 2023
Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions Leading specialist biomarker and bioanalysis solutions provider further strengthens global management team.August 19, 2022
Synexa Life Sciences expands operations in North America with new Rockville laboratory site New site supports unique and seamless workflows that narrow the gap between preclinical and clinical phasesJune 13, 2022
Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals.May 19, 2022
Synexa Life Sciences announces strategic growth plans and strengthening of its executive team Delivering on growth strategies to become the global market leader in specialist biomarker and bioanalytical services.May 18, 2022
Synexa Life Sciences Co-founder and CEO to become company’s Chairman Leading biomarker and bioanalysis company lays the foundation for future growth and expansion plan.May 13, 2022
